Water Aerobics Tied to Improvements in Body Weight for Overweight, Obesity
THURSDAY, March 20, 2025 -- Water aerobics (WAs) improves body weight and waist circumference for adults with overweight or obesity, according to a review published online March 11 in BMJ Open.
Ziyan Ding, from Pukyong National University in Busan, South Korea, and colleagues conducted a systematic literature review to examine the effects of WAs on body composition.
Based on 10 included randomized controlled studies (286 participants), the researchers found that WAs were able to reduce body weight (weighted mean differences [WMD], −2.69; I2 = 0.0 percent) and waist circumference (WMD, −2.75; I2 = 27.0 percent). However, the effect of WAs on other body indicators was not significant. The certainty of evidence was low for body mass index, lean mass, fat mass, waist-to-hip ratio, and hip circumference based on the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) assessment and very low for percent body fat. The evidence was of moderate certainty for body weight and waist circumference.
"Health professionals should approach these results with caution and prioritize interventions with stronger evidence when aiming to target these specific outcomes," the authors write. "However, the moderate certainty of evidence for body weight and waist circumference supports the use of WAs as an effective intervention for reducing overall body weight and central obesity, which were critical factors in managing obesity-related health risks."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Cancer Survival Lower in Rural Areas
WEDNESDAY, Oct. 1, 2025 -- Five-year cancer survival rates for each stage of cancer (localized, regional, and distant) is lower in nonmetropolitan areas for Black and White...
Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists
WEDNESDAY, Oct. 1, 2025 -- People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems compared with patients treated...
Loss of Smell May Linger After COVID-19
WEDNESDAY, Oct. 1, 2025 -- Self-reported change or loss in smell or taste is an accurate signal of verified hyposmia after COVID-19, although there is also a high rate of hyposmia...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.